MEDIFAST INC (MED) - Total Assets

Latest as of September 2025: $268.21 Million USD

Based on the latest financial reports, MEDIFAST INC (MED) holds total assets worth $268.21 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is MEDIFAST INC's book value for net asset value and shareholders' equity analysis.

MEDIFAST INC - Total Assets Trend (1996–2024)

This chart illustrates how MEDIFAST INC's total assets have evolved over time, based on quarterly financial data.

MEDIFAST INC - Asset Composition Analysis

Current Asset Composition (December 2024)

MEDIFAST INC's total assets of $268.21 Million consist of 75.4% current assets and 24.6% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $90.93 Million 32.0%
Accounts Receivable $0.00 0.0%
Inventory $42.42 Million 14.9%
Property, Plant & Equipment $48.68 Million 17.1%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (1996–2024)

This chart illustrates how MEDIFAST INC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of MEDIFAST INC.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: MEDIFAST INC's current assets represent 75.4% of total assets in 2024, an increase from 54.4% in 1996.
  • Cash Position: Cash and equivalents constituted 32.0% of total assets in 2024, up from 2.5% in 1996.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 1996.
  • Asset Diversification: The largest asset category is cash and equivalents at 32.0% of total assets.

MEDIFAST INC Competitors by Total Assets

Key competitors of MEDIFAST INC based on total assets are shown below.

Company Country Total Assets
Propel Funeral Partners Ltd
AU:PFP
Australia AU$655.12 Million
Apiam Animal Health Ltd
AU:AHX
Australia AU$255.80 Million
Shine Justice Ltd
AU:SHJ
Australia AU$589.49 Million
Mayfield Childcare Ltd
AU:MFD
Australia AU$221.55 Million
Af Legal Group Ltd
AU:AFL
Australia AU$27.86 Million
MiniLuxe Holding Corp
V:MNLX
Canada CA$13.59 Million
Goodfood Market Corp
TO:FOOD
Canada CA$39.06 Million
Hube Yangfan Holding Co Ltd
SHG:600421
China CN¥183.02 Million

MEDIFAST INC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.45 3.11 2.10
Quick Ratio 3.95 2.55 1.62
Cash Ratio 2.13 1.59 0.00
Working Capital $161.12 Million $152.60 Million $122.96 Million

MEDIFAST INC - Advanced Valuation Insights

This section examines the relationship between MEDIFAST INC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.55
Latest Market Cap to Assets Ratio 0.42
Asset Growth Rate (YoY) -8.3%
Total Assets $284.21 Million
Market Capitalization $118.38 Million USD

Valuation Analysis

Below Book Valuation: The market values MEDIFAST INC's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: MEDIFAST INC's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for MEDIFAST INC (1996–2024)

The table below shows the annual total assets of MEDIFAST INC from 1996 to 2024.

Year Total Assets Change
2024-12-31 $284.21 Million -8.29%
2023-12-31 $309.91 Million -1.99%
2022-12-31 $316.21 Million -20.61%
2021-12-31 $398.33 Million +44.28%
2020-12-31 $276.08 Million +41.83%
2019-12-31 $194.65 Million +14.89%
2018-12-31 $169.43 Million +16.10%
2017-12-31 $145.93 Million +20.39%
2016-12-31 $121.22 Million +3.32%
2015-12-31 $117.33 Million +1.22%
2014-12-31 $115.91 Million -12.62%
2013-12-31 $132.65 Million +1.84%
2012-12-31 $130.25 Million +23.27%
2011-12-31 $105.67 Million +12.34%
2010-12-31 $94.06 Million +46.65%
2009-12-31 $64.14 Million +25.67%
2008-12-31 $51.04 Million +16.73%
2007-12-31 $43.72 Million +18.41%
2006-12-31 $36.93 Million +20.89%
2005-12-31 $30.55 Million +17.63%
2004-12-31 $25.97 Million +7.16%
2003-12-31 $24.23 Million +145.06%
2002-12-31 $9.89 Million +194.55%
2001-12-31 $3.36 Million +7.42%
2000-12-31 $3.12 Million +47.96%
1999-12-31 $2.11 Million -79.57%
1998-12-31 $10.34 Million +48.91%
1997-12-31 $6.94 Million -39.36%
1996-12-31 $11.45 Million --

About MEDIFAST INC

NYSE:MED USA Personal Services
Market Cap
$139.48 Million
Market Cap Rank
#18572 Global
#4103 in USA
Share Price
$12.69
Change (1 day)
-2.53%
52-Week Range
$9.53 - $15.22
All Time High
$294.26
About

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. … Read more